vs
CUMBERLAND PHARMACEUTICALS INC（CPIX）与FIRST US BANCSHARES, INC.（FUSB）财务数据对比。点击上方公司名可切换其他公司
CUMBERLAND PHARMACEUTICALS INC的季度营收约是FIRST US BANCSHARES, INC.的1.3倍（$13.7M vs $10.4M），FIRST US BANCSHARES, INC.净利率更高（20.4% vs -10.3%，领先30.8%），CUMBERLAND PHARMACEUTICALS INC同比增速更快（31.1% vs 7.1%），FIRST US BANCSHARES, INC.自由现金流更多（$9.1M vs $3.0K），过去两年CUMBERLAND PHARMACEUTICALS INC的营收复合增速更高（26.9% vs 2.6%）
坎伯兰制药是一家专科制药企业，专注于开发、生产和商业化品牌处方药物，核心产品覆盖急症护理、胃肠病、疼痛管理及罕见病治疗领域，主要运营市场为美国，为相关医护人员与患者提供服务。
第一美国银行控股公司是一家银行控股企业，核心子公司第一公民银行在美国23个州经营着超过500家网点，另一家子公司硅谷银行则在15个州设有39个办事处，是美国规模较大的银行机构之一，总部位于北卡罗来纳州罗利。
CPIX vs FUSB — 直观对比
营收规模更大
CPIX
是对方的1.3倍
$10.4M
营收增速更快
CPIX
高出24.0%
7.1%
净利率更高
FUSB
高出30.8%
-10.3%
自由现金流更多
FUSB
多$9.1M
$3.0K
两年增速更快
CPIX
近两年复合增速
2.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.7M | $10.4M |
| 净利润 | $-1.4M | $2.1M |
| 毛利率 | 83.6% | — |
| 营业利润率 | -10.0% | 28.1% |
| 净利率 | -10.3% | 20.4% |
| 营收同比 | 31.1% | 7.1% |
| 净利润同比 | 25.8% | 24.2% |
| 每股收益（稀释后） | $-0.09 | $0.36 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CPIXFUSB
| Q4 25 | $13.7M | $10.4M | ||
| Q3 25 | $8.3M | $10.5M | ||
| Q2 25 | $10.8M | $10.3M | ||
| Q1 25 | $11.7M | $9.8M | ||
| Q4 24 | $10.4M | $9.7M | ||
| Q3 24 | $9.1M | $10.1M | ||
| Q2 24 | $9.8M | $10.0M | ||
| Q1 24 | $8.5M | $9.9M |
净利润CPIXFUSB
| Q4 25 | $-1.4M | $2.1M | ||
| Q3 25 | $-1.9M | $1.9M | ||
| Q2 25 | $-740.7K | $155.0K | ||
| Q1 25 | $1.3M | $1.8M | ||
| Q4 24 | $-1.9M | $1.7M | ||
| Q3 24 | $-1.5M | $2.2M | ||
| Q2 24 | $-1.1M | $2.1M | ||
| Q1 24 | $-1.9M | $2.1M |
毛利率CPIXFUSB
| Q4 25 | 83.6% | — | ||
| Q3 25 | 88.1% | — | ||
| Q2 25 | 81.4% | — | ||
| Q1 25 | 87.8% | — | ||
| Q4 24 | 81.1% | — | ||
| Q3 24 | 85.4% | — | ||
| Q2 24 | 82.6% | — | ||
| Q1 24 | 81.5% | — |
营业利润率CPIXFUSB
| Q4 25 | -10.0% | 28.1% | ||
| Q3 25 | -23.7% | 23.9% | ||
| Q2 25 | -6.9% | 1.6% | ||
| Q1 25 | 11.0% | 23.8% | ||
| Q4 24 | -17.7% | 23.8% | ||
| Q3 24 | -18.6% | 29.2% | ||
| Q2 24 | -10.4% | 27.4% | ||
| Q1 24 | -22.0% | 27.8% |
净利率CPIXFUSB
| Q4 25 | -10.3% | 20.4% | ||
| Q3 25 | -23.4% | 18.4% | ||
| Q2 25 | -6.8% | 1.5% | ||
| Q1 25 | 10.7% | 18.1% | ||
| Q4 24 | -18.2% | 17.6% | ||
| Q3 24 | -17.0% | 22.0% | ||
| Q2 24 | -11.0% | 21.2% | ||
| Q1 24 | -22.9% | 21.3% |
每股收益（稀释后）CPIXFUSB
| Q4 25 | $-0.09 | $0.36 | ||
| Q3 25 | $-0.13 | $0.32 | ||
| Q2 25 | $-0.05 | $0.03 | ||
| Q1 25 | $0.08 | $0.29 | ||
| Q4 24 | $-0.13 | $0.29 | ||
| Q3 24 | $-0.11 | $0.36 | ||
| Q2 24 | $-0.08 | $0.34 | ||
| Q1 24 | $-0.14 | $0.34 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $11.4M | $73.5M |
| 总债务越低越好 | — | $10.9M |
| 股东权益账面价值 | $24.9M | $105.6M |
| 总资产 | $76.8M | $1.2B |
| 负债/权益比越低杠杆越低 | — | 0.10× |
8季度趋势，按日历期对齐
现金及短期投资CPIXFUSB
| Q4 25 | $11.4M | $73.5M | ||
| Q3 25 | $15.2M | $54.7M | ||
| Q2 25 | $16.1M | $54.0M | ||
| Q1 25 | $15.1M | $56.0M | ||
| Q4 24 | $18.0M | $47.2M | ||
| Q3 24 | $17.5M | $82.3M | ||
| Q2 24 | $17.3M | $58.2M | ||
| Q1 24 | $18.5M | $60.2M |
总债务CPIXFUSB
| Q4 25 | — | $10.9M | ||
| Q3 25 | — | $10.9M | ||
| Q2 25 | — | $10.9M | ||
| Q1 25 | — | $10.9M | ||
| Q4 24 | — | $10.9M | ||
| Q3 24 | — | $10.9M | ||
| Q2 24 | — | $10.8M | ||
| Q1 24 | — | $10.8M |
股东权益CPIXFUSB
| Q4 25 | $24.9M | $105.6M | ||
| Q3 25 | $26.1M | $104.2M | ||
| Q2 25 | $28.0M | $101.9M | ||
| Q1 25 | $28.7M | $101.2M | ||
| Q4 24 | $22.9M | $98.6M | ||
| Q3 24 | $24.8M | $98.5M | ||
| Q2 24 | $26.3M | $93.8M | ||
| Q1 24 | $27.5M | $92.3M |
总资产CPIXFUSB
| Q4 25 | $76.8M | $1.2B | ||
| Q3 25 | $65.9M | $1.1B | ||
| Q2 25 | $67.9M | $1.1B | ||
| Q1 25 | $69.9M | $1.1B | ||
| Q4 24 | $75.6M | $1.1B | ||
| Q3 24 | $76.7M | $1.1B | ||
| Q2 24 | $78.5M | $1.1B | ||
| Q1 24 | $81.5M | $1.1B |
负债/权益比CPIXFUSB
| Q4 25 | — | 0.10× | ||
| Q3 25 | — | 0.10× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.11× | ||
| Q4 24 | — | 0.11× | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.12× | ||
| Q1 24 | — | 0.12× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.0K | $12.3M |
| 自由现金流经营现金流 - 资本支出 | $3.0K | $9.1M |
| 自由现金流率自由现金流/营收 | 0.0% | 87.2% |
| 资本支出强度资本支出/营收 | 0.0% | 31.1% |
| 现金转化率经营现金流/净利润 | — | 5.79× |
| 过去12个月自由现金流最近4个季度 | $4.8M | $16.0M |
8季度趋势，按日历期对齐
经营现金流CPIXFUSB
| Q4 25 | $3.0K | $12.3M | ||
| Q3 25 | $187.2K | $4.2M | ||
| Q2 25 | $843.8K | $3.9M | ||
| Q1 25 | $3.9M | $1.8M | ||
| Q4 24 | $1.9M | $7.8M | ||
| Q3 24 | $475.5K | $1.9M | ||
| Q2 24 | $-855.7K | $2.5M | ||
| Q1 24 | $-2.1M | $825.0K |
自由现金流CPIXFUSB
| Q4 25 | $3.0K | $9.1M | ||
| Q3 25 | $163.4K | $3.6M | ||
| Q2 25 | $817.3K | $1.6M | ||
| Q1 25 | $3.9M | $1.7M | ||
| Q4 24 | $1.9M | $5.7M | ||
| Q3 24 | $460.1K | $1.3M | ||
| Q2 24 | $-862.8K | $2.3M | ||
| Q1 24 | $-2.2M | $-142.0K |
自由现金流率CPIXFUSB
| Q4 25 | 0.0% | 87.2% | ||
| Q3 25 | 2.0% | 34.2% | ||
| Q2 25 | 7.5% | 16.0% | ||
| Q1 25 | 32.9% | 17.2% | ||
| Q4 24 | 18.2% | 58.2% | ||
| Q3 24 | 5.1% | 12.7% | ||
| Q2 24 | -8.8% | 23.5% | ||
| Q1 24 | -25.6% | -1.4% |
资本支出强度CPIXFUSB
| Q4 25 | 0.0% | 31.1% | ||
| Q3 25 | 0.3% | 5.9% | ||
| Q2 25 | 0.2% | 21.8% | ||
| Q1 25 | 0.4% | 0.7% | ||
| Q4 24 | 0.0% | 21.6% | ||
| Q3 24 | 0.2% | 6.6% | ||
| Q2 24 | 0.1% | 2.0% | ||
| Q1 24 | 0.5% | 9.8% |
现金转化率CPIXFUSB
| Q4 25 | — | 5.79× | ||
| Q3 25 | — | 2.18× | ||
| Q2 25 | — | 25.16× | ||
| Q1 25 | 3.10× | 0.99× | ||
| Q4 24 | — | 4.53× | ||
| Q3 24 | — | 0.87× | ||
| Q2 24 | — | 1.20× | ||
| Q1 24 | — | 0.39× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
